Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs149758711 | chr2:61841422 | C/CT | 4.54E-8 | 177 | 15.42 | 17.4 | 3.85 | KM Plot |
| PAAD | rs149904649 | chr2:70488972 | AT/A | 0 | 178 | 15.33 | 18.43 | 1.03 | KM Plot |
| PAAD | rs150164772 | chr1:227536463 | C/T | 1.03E-5 | 175 | 15.55 | 15.65 | 3.9 | KM Plot |
| PAAD | rs150263121 | chr7:154676188 | GAC/G | 8.55E-14 | 174 | 15.82 | 14.33 | 3.43 | KM Plot |
| PAAD | rs150344071 | chr11:125651986 | C/T | 5.8E-5 | 178 | 15.95 | 12.2 | 4.1 | KM Plot |
| PAAD | rs150359083 | chr11:34775367 | AC/A | 5.48E-6 | 176 | 15.57 | 12.17 | 3.67 | KM Plot |
| PAAD | rs150411101 | chr17:27018863 | G/A | 1.5E-5 | 173 | 15.43 | 16.07 | 3.67 | KM Plot |
| PAAD | rs150450796 | chr11:68494649 | C/G | 1.06E-9 | 177 | 15.57 | 14.03 | 2.2 | KM Plot |
| PAAD | rs150528260 | chr11:125628394 | A/C | 7.29E-5 | 178 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs150749415 | chr1:227464391 | A/G | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs150786203 | chr11:125585040 | T/C | 0.000108 | 178 | 16.08 | 14.37 | 5.03 | KM Plot |
| PAAD | rs150792143 | chr2:70494429 | T/A | 0 | 178 | 15.33 | 18.43 | 1.03 | KM Plot |
| PAAD | rs150833594 | chr1:16363148 | AG/A | 1.25E-6 | 175 | 15.4 | 15.53 | 3.43 | KM Plot |
| PAAD | rs151070700 | chr21:37023369 | AAACT/A | 2.29E-6 | 178 | 5.52 | 17.4 | 15.13 | KM Plot |
| PAAD | rs154061 | chr5:94595494 | A/G | 5.05E-5 | 173 | 0.3 | 18.48 | 14.63 | KM Plot |